Molecular Screening Services is the analysis of human genetic makeup to screen a panel of mutation/genetic variation which may predispose an individual to either increased or decreased risk of developing a condition/disease.
While CAN12™ evaluates the lifetime risk of developing 12 prevalent types of cancers, FH1536™ evaluates the lifetime risk of developing Hypercholesterolemia (high blood cholesterol level) and determines whether the condition is due to familial factor (genetically associated).
No comments:
Post a Comment